SMARCA4 and gastric carcinoma: Assessment of genetic alterations in BRG1 presentin the tumors or in eight gastric carcinoma cell lines failed to identifyany mutations, suggesting that elevated expression was associated with thedevelopment and progression of the tumor [111].